Stable expression of a cDNA encoding a human beta 1 --> 3galactosyltransferase responsible for lacto-series type 1 core chain synthesis in non-expressing cells: variation in the nature of cell surface antigens expressed.
Stable expression of a cDNA encoding a human beta 1 --> 3galactosyltransferase responsible for lacto-series type 1 core chain synthesis in non-expressing cells: variation in the nature of cell surface antigens expressed.
复制标题
编码人β1->3半乳糖基转移酶的cDNA在非表达细胞中稳定表达,该酶负责乳系列1型核心链的合成:表达的细胞表面抗原性质的变化。
DOI:
10.1002/jcb.240500207
复制
发表时间:
1992
影响因子:
4
通讯作者:
Holmes,EH
中科院分区:
文献类型:
--
作者:
Sherwood,AL;Greene,TG;Holmes,EH
Transient expression of a human colonic adenocarcinoma Colo 205 cell derived cDNA in cell lines which ordinarily express only neolacto‐series glycolipids has resulted in the expression of a β1 → 3galactosyltransferase gene responsible for synthesis of glycolipids based upon the lacto‐series type 1 core chain. Calcium phosphate transfected cells were panned on anti‐lgM coated plates after initial treatment with a combination of monoclonal antibodies specific for type 1 chain terminal structures (TE‐3) and a very broadly specific antibody reactive with multiple type 1 chain derivatives (TE‐2). Adherent cells after panning were capable of efficiently transferring Gal in β1 → 3‐linkage to the acceptor glycolipid Lc3. Using these reagents, clones of stably transfected human colonic adenocarcinoma HCT‐15 cells were produced and isolated. Parental HCT‐15 cells do not express type 1 chain based antigens. The nature of the type 1 chain based antigens produced in each of these clones was analyzed by solid phase antibody binding assays. Three types of behavior were observed. Formation of type 1 terminal structures that were either exclusively sialylated or fucosylated, or a mixture of sialylated and fucosylated determinants occurred. In contrast, no difference in type 2 antigen expression between any clone and the parental cells was observed. These data suggest that coordination of subsequent reactions capable of modifying type 1 chain structures is not the same in all clones. The relationship of these results to aspects of cellular regulation of carbohydrate biosynthesis is discussed. © 1992 Wiley‐Liss, Inc.